当前位置:首页 / 单纯血浆置换与其联合双重血浆分子吸附系统治疗重型肝炎患者效果比较分析
论著 | 更新时间:2018-10-24
|
单纯血浆置换与其联合双重血浆分子吸附系统治疗重型肝炎患者效果比较分析
Comparison of the efficacy of simple plasma exchange and plasma exchange combined with DPMAS in the treatment of severe hepatitis

内科 201813卷05期 页码:744-746

作者机构:广西玉林市红十字会医院感染科,玉林市537000

基金信息:

DOI:DOI:10.16121/j.cnki.cn45-1347/r.2018.05.20

  • 中文简介
  • 英文简介
  • 参考文献
目的比较单纯血浆置换(PE)与其联合双重血浆分子吸附系统(DPMAS)治疗重型肝炎患者的临床疗效。方法选取2012年1月至2017年12月我院收治的重型肝炎患者60例为研究对象,按随机数字表法分为对照组和观察组,每组30例。对照组患者采用PE治疗,观察组患者采用PE联合DPMAS治疗。检测比较两组患者治疗前和治疗一次后的血清总胆红素(TBIL)水平、直接胆红素(DBIL)水平、谷丙转氨酶(ALT)水平、凝血酶原时间(PT)、胆碱酯酶(CHE)水平、白蛋白(ALB)及球蛋白(GLO)水平。结果治疗后,两组患者血清TBIL、DBIL、ALT水平均明显降低,观察组患者TBIL、DBIL、ALT水平显著低于对照组,差异有统计学意义(P<0.05);治疗后两组患者血清PT均显著降低、CHE水平均显著升高,观察组患者血清PT水平显著低于对照组、CHE水平显著高于对照组,差异有统计学意义(P<0.05);治疗后两组患者血清中ALB、GLO水平均明显升高,观察组患者ALB、GLO水平显著高于对照组,差异有统计学意义(P<0.05)。结论PE联用DPMAS治疗重型肝炎患者能有效阻断肝损害的恶性循环,清除体内中、小分子代谢毒素及免疫复合物等大分子物质,减少血液有形成分的破坏,有效降低多脏器功能衰竭的发生风险。
ObjectiveTo explore the therapeutic effect of simple plasma exchange (PE) and PE combined with double plasma molecular adsorbent system (DPMAS) on patients with severe hepatitis. Methods60 patients with severe hepatitis treated in our hospital from January 2012 to December 2017 were selected and randomly divided into observation group and control group, with 30 cases in each group. The control group were treated with PE, the observation group were treated with PE combined with DPMAS. The serum total bilirubin (TBIL) level, serum direct bilirubin (DBIL) level, alanine aminotransferase (ALT) level, prothrombin time (PT), cholinesterase (CHE) level, albumin (ALB) level and globulin (GLO) level before and after treatment were compared between two groups. ResultsAfter treatment, the levels serum TBIL, DBIL and ALT were significantly decreased in the two groups. The levels of TBIL, DBIL and ALT in the observation group were significantly lower than those in the control group (P<0.05). After treatment, the serum PT in the two groups were significantly decreased and the CHE level were significantly increased; the serum PT of the observation group was significantly lower than the control group, CHE level was significantly higher than the control group, the difference were statistically significant (P<0.05). After treatment, the levels of serum ALB and GLO in the two groups were significantly higher than before treatment, the levels of serum ALB and GLO in the observation group were significantly higher than those in the control group (P<0.05). ConclusionPE combined with DPMAS in the treatment of severe hepatitis patients can improve the liver damage, remove macromolecules such as small and medium molecular metabolic toxins and immune complexes, reduce the damage of blood forming components, and effectively reduce the risk occurrence of multiple organ failure.

2072

浏览量

988

下载量

0

CSCD

工具集